CARLA WALKER: Open Payments
NPI 1740704774 · FORT SMITH, AR. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$946 in 53 payments from 19 companies in 2025. Trend: 2023 $1,389 · 2024 $1,057 · 2025 $946
Food & beverage: $946
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 12 | $251 |
| Amgen Inc. | 6 | $99 |
| Novo Nordisk Inc | 5 | $87 |
| ABBVIE INC. | 4 | $77 |
| GlaxoSmithKline, LLC. | 5 | $72 |
| Bayer Healthcare Pharmaceuticals Inc. | 4 | $66 |
| Sumitomo Pharma America, Inc. | 2 | $37 |
| Exact Sciences Corporation | 2 | $35 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 2 | $31 |
| PFIZER INC. | 2 | $29 |
Products named: AIRSUPRA, BREZTRI, Kerendia, Ozempic, OTEZLA, TRELEGY ELLIPTA, UBRELVY, GEMTESA.
Industry payments across AR — which companies pay providers there.
